Parkinson-Immunisierung in Sicht?

[Article in German]

Affiliations

Review

[Article in German]

Richard Dodel. MMW Fortschr Med. 2021 May.

. 2021 May;163(9):28.

doi: 10.1007/s15006-021-9943-2.

¹ Lehrstuhl für Geriatrie, Universität Duisburg-Essen, Germaniastraße 1-3, 45356, Essen, Deutschland.

No abstract available

Comment on

Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial.
Volc D, Poewe W, Kutzelnigg A, Lührs P, Thun-Hohenstein C, Schneeberger A, Galabova G, Majbour N, Vaikath N, El-Agnaf O, Winter D, Mihailovska E, Mairhofer A, Schwenke C, Staffler G, Medori R. Volc D, et al. Lancet Neurol. 2020 Jul;19(7):591-600. doi: 10.1016/S1474-4422(20)30136-8. Lancet Neurol. 2020. PMID: 32562684 Clinical Trial.